van der Voorn, S.M.; Bourfiss, M.; Muller, S.A.; Çimen, T.; Saguner, A.M.; Duru, F.; te Riele, A.S.J.M.; Remme, C.A.; van Veen, T.A.B.
Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy. Biomedicines 2023, 11, 813.
https://doi.org/10.3390/biomedicines11030813
AMA Style
van der Voorn SM, Bourfiss M, Muller SA, Çimen T, Saguner AM, Duru F, te Riele ASJM, Remme CA, van Veen TAB.
Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy. Biomedicines. 2023; 11(3):813.
https://doi.org/10.3390/biomedicines11030813
Chicago/Turabian Style
van der Voorn, Stephanie M., Mimount Bourfiss, Steven A. Muller, Tolga Çimen, Ardan M. Saguner, Firat Duru, Anneline S. J. M. te Riele, Carol Ann Remme, and Toon A. B. van Veen.
2023. "Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy" Biomedicines 11, no. 3: 813.
https://doi.org/10.3390/biomedicines11030813
APA Style
van der Voorn, S. M., Bourfiss, M., Muller, S. A., Çimen, T., Saguner, A. M., Duru, F., te Riele, A. S. J. M., Remme, C. A., & van Veen, T. A. B.
(2023). Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy. Biomedicines, 11(3), 813.
https://doi.org/10.3390/biomedicines11030813